Antrogen ranked among the top searched stocks for 2 days in the past month.

As of 10:32 AM on the 25th, Antrogen is trading at 53,200 KRW, down 1.85% from the previous day. This represents a 57.86% increase compared to May 19. Antrogen is known as a developer and seller of stem cell therapies.

Today, foreigners are tentatively recorded as net sellers of 1,698 shares. Over the past 5 days, individual investors have net sold 48,603 shares, while foreigners and institutions have net bought 34,466 shares and net sold 9,450 shares, respectively.

On May 21, Antrogen became a market issue with the headline "Diabetic Foot Ulcer Treatment Receives FDA Approval, Surges for Second Day."



[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)
※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and financial AI specialist Thinkpool.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing